Aktiesnakken — Juli 2010
-
de kan jo have fået det som opgave af en kunde der ligger short længere oppe
-
dayne, genmab omsætningen er traditionelt 250-350K. 500K+ viser at der er flere der vil ind og nok de større huse
-
det er mit postulat
-
kørt ned af CSB
-
og UBs. Så kan vi starte forfra
-
netto minus ligesom igår http://hopey.netfonds.no/paperbroker.php?paper=GEN.CPH
-
jeg er meget imponeret over deres arbejde
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind